Intra-arterial chemotherapy for retinoblastoma: The beginning of a long journey

Clinical and Experimental Ophthalmology

Volumn 38, Issue 6, 2010, Pages 638-643

  Shields, Carol L ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Chemotherapy; Eye; Intra arterial chemotherapy; Retina; Retinoblastoma

Indexed keywords

CISPLATIN; LIPOSOME; MELPHALAN; NIMUSTINE; VASCULOTROPIN ANTIBODY; ANTINEOPLASTIC AGENT;

ARTERY OCCLUSION; ARTIFICIAL EMBOLISM; BLEEDING; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER CONTROL; CATHETERIZATION; CHILDHOOD CANCER; CONSERVATIVE TREATMENT; CYTOPENIA; EMBOLISM; EYELID EDEMA; FLUOROSCOPY; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; INFECTION; ISCHEMIA; OPHTHALMIC ARTERY; OSTEOSARCOMA; PTOSIS; RADIATION EXPOSURE; RADIOSENSITIZATION; RETINA DETACHMENT; RETINOBLASTOMA; REVIEW; RISK; STENOSIS; THROMBOSIS; TUMOR SEEDING; UNSPECIFIED SIDE EFFECT; INTRAARTERIAL DRUG ADMINISTRATION; RETINAL NEOPLASMS;

ANTINEOPLASTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 77951298944     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02297.x     Document Type: Review

References (31)

1. Shields JA, Shields CL. Management of retinoblastoma. Intraocular Tumors. An Atlas and Textbook 2008, 333-52. Shields JA, Shields CL. In, eds., 2nd, edn., Philadelphia, PA, Lippincott Williams and Wilkins
2. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 1988, 95:1583-7.
3. Wong FL, Boice JD, Abramson DH. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997, 278:1262-7.
4. Shields CL, Mashayekhi A, Au AK. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006, 113:2276-80.
5. Demirci H, Shields CL, Meadows AT, Shields JA. Long term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol 2005, 123:1525-30.
6. Friedman DL, Himelstein B, Shields CL. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000, 18:12-17.
7. Gombos DS, Hungerford J, Abramson DH. Secondary acute myelogenous leukemia in patients with retinoblastoma. Is chemotherapy a factor? Ophthalmology 2007, 114:1378-83.
8. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina 2009, 29:1207-9.
9. Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res 1987, 78:858-68.
10. Kaneko A, Ise T, Oohira M. Chemo-thermotherapy was successful in two cases of recurrence of intraocular retinoblastoma after irradiation. Jpn J Ophthalmol Clin Ophthalmol 1990, 44:289-92.
11. Kaneko A. Japanese contributions to ocular oncology. Int J Clin Oncol 1999, 4:321-6.
12. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004, 9:69-73.
13. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 2004, 9:1-6.
14. Abramson DH, Dunke IJ, Brodie SE. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmoloy 2008, 115:1398-404.
15. Lin P, O'Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol 2009, 148:192-8.
16. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Factors predictive of recurrence of retinal tumor, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002, 120:460-4.
17. Dunkel I, Gobin YP, Salvaggio K. Systemic (non-ocular) toxicity associated with intra-arterial melphalan chemotherapy. International Society of Ocular Oncology Meeting; 8-12 Sep 2009, Cambridge, England
18. Mahajan A, Schelingerhout D, Woo SY, Gombos D. Evaluation of the radiation exposure of angiography for intra-arterial chemotherapy administration for retinoblastoma. International Society of Ocular Oncology Meeting; 8-12 Sep 2009, Cambridge, England
19. Vijayakrishnan R, Shields CL, Ramasubramanian A. Radiation toxicity during intra-arterial chemotherapy for retinoblastoma - Should we be concerned? Arch Opthalmol 2010, in press
20. Brenner DJ, Elliston MA. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004, 232:735-8.
21. Mills DM, Tsai S, Meyer DR, Belden C. Pediatric ophthalmic computed tomographic scanning and associated cancer risk. Am J Ophthalmol 2006, 142:1046-53.
22. Madajewicz S, Chowhan N, Tfayli A. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer 2000, 88:2350-6.
23. Shapiro WR, Green SB, Burger PC. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5 fluoruracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992, 76:722-81.
24. Kochi M, Kitamura I, Goto T. Randomize comparison of intr-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma. J Neurooncol 2000, 49:63-70.
25. Imbesi F, Marchioni E, Benericetti E. A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas. Anticancer Res 2006, 26:553-8.
26. Anderson PM, Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol Rep 2006, 8:310-15.
27. Jaffe N, Knapp J, Chuang VP. Osteosarcoma: intra-arterial treatment of the primary tumor with Cis-Diamine-Dichloroplatinum II. Cancer 1983, 51:402-7.
28. Jaffe N, Prudrich J, Knapp J. Treatment of primary osteosarcoma with intraarterial and intravenous high dose metrhotrexate. J Clin Oncol 1983, 3:12-18.
29. Winkler K, Bielack S, Delling G. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer 1990, 66:1703-10.
30. Stine KC, Hockenbery MJ, Harrelson J. Systemic doxorubicin and intra-arterial cisplatin presoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma. Cancer 1989, 2:1-16.
31. Bacci G, Ferrari S, Tienghi A. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. ESJO 2001, 27:98-104.